INSIGHTS ON CLINICAL TRIAL DESIGN
-
![Medical safety, drug monitoring, clinical research, pharmacovigilance-GettyImages-2242535196]( "What Most Psychiatric Drug Development Programmes Learn Too Late")
What Most Psychiatric Drug Development Programmes Learn Too LateClinical phase completion doesn’t end uncertainty. Six key questions on brain exposure, pharmacology, therapeutic window, and patient variability can reveal whether the molecule failed, or the mechanism.
-
![GettyImages-1464245432 payments]( "How Smarter Financial Strategies Improve Trial Performance")
How Smarter Financial Strategies Improve Trial PerformanceCROs play a critical role in ensuring the financial and operational success of clinical trials, yet outdated budgets and inefficient payment processes continue to create challenges for sites.
-
![GettyImages-1388560078-chimeric-antigen-receptor-cell]( "Developing And Validating Clinical Receptor Occupancy Pharmacodynamic Biomarker Assays")
Developing And Validating Clinical Receptor Occupancy Pharmacodynamic Biomarker AssaysReceptor occupancy (RO) assays assess drug-target engagement and support PK/PD modeling. Accurate RO requires customized assays using stabilized blood to monitor CD6 modulation in autoimmune therapy.
-
![Diversity-Diverse-word-GettyImages-1282026341]( "Overcoming Barriers To Participation")
Overcoming Barriers To ParticipationExplore effective strategies to enhance diversity and inclusion in clinical trials by supporting underrepresented patient groups, ensuring equitable health outcomes and broader representation.
-
The Evolving Role Of Healthy Participants In Early Immuno-Oncology Trials11/21/2025
Explore how leveraging healthy participants, advanced immune-challenge models, and high-dimensional biomarker analyses can transform early immuno-oncology development.
-
Flexible Supply Strategies For Complex Clinical Trials3/25/2026
Explore how demand-led, decentralized clinical supply models are reshaping complex trials by reducing waste, accelerating timelines, and advancing patient-centric access to investigational therapies.
-
Sustaining Participation In A 20-Year Alzheimer's Family Study8/14/2026
Learn how home-based visits can reduce burden, improve retention, and support long-term follow-up in complex clinical studies requiring years of continuous participation.
-
Bridging The Trust Gap: How Patient Advocacy Groups Transforms Trial Recruitment10/27/2025
Explore how collaboration between researchers and Patient Advocacy Groups (PAGs) can bridge the trust gap that undermines recruitment and can make trial participation more approachable and meaningful.
-
Navigating the Next Wave of CNS Development10/8/2026
Learn how advances in biomarkers, AI, digital endpoints, and translational science can support more informed strategies across CNS drug development.
CLINICAL TRIAL DESIGN SOLUTIONS
-
TrialScope Disclose delivers the proven solutions clinical trial sponsors need to centralize, track, register, and comply with clinical trial disclosure processes, mitigating compliance risks while giving them greater control over their own clinical trial disclosure reputation.
-
![Medical data iStock-1210343139]( "Accelerate Clinical Trial Cycle Times With Citeline Study Feasibility")
Citeline Study Feasibility is a platform that combines subject-matter expertise and machine learning to develop predictive insights for feasibility planning. Clinical trial sponsors can use these insights to identify key data drivers and model their impact, build and simulate feasibility scenarios, accelerate timelines, and make better decisions than with statistical methods alone.
-
![Business people talking-GettyImages-1362264935]( "A Hands-On Approach To End-To-End Rater Services")
If rater quality is a risk your study can't afford to take, now is the time to evaluate whether your current approach has the structure to support it.
-
![meeting]( "Get It Right The First Time: Strategic Clinical Development")
Start early and get it right the first time. Course correct with a changing landscape. Overcome obstacles within clinical development. Collaborate with the best strategists and problem-solvers in clinical development.
-
![GettyImages-2174865907 workflow, lab, cell therapy]( "High-Content Flow Cytometry")
Flow cytometry is a foundational tool in modern drug development, and its application in receptor occupancy assays has become essential for evaluating therapeutic engagement with disease targets.
